Quadruplicate 5-ml samples ofS. aureus MF-31, S-6, and 210 were removed from Trypticase soy broth cultures (=-2 x 109 cells per ml) and were added to an equal volume of frozen TM buffer [10 mM tris(hydroxymethyl)aminomethane, pH 7.6, 0.1 mM MgCl2] containing 20% sucrose and 0.02 mg of lysostaphin per ml (237 U/mg, Schwarz/Mann, Orangeburg, N.Y.), hereafter called lysostaphin ice. Additionally, duplicate 5-ml samples of each strain were added to equal volumes of frozen TM buffer alone and also to lysostaphin ice made without sucrose (prepared as above less sucrose). All suspensions were mixed at room temperature until the ice was melted, and the cells were sedimented by centrifugation. The supernatant was removed after centrifugation. Cell pellets centrifuged through TM buffer alone (group 1), lysostaphin ice without sucrose (group 2), and two samples centrifuged through lysostaphin ice (group 3) were frozen. The remaining cell pellets that were centrifuged through lysostaphin ice were not frozen (group 4).
One sample from each of the four groups was suspended in 5 ml of TM buffer and incubated for 10 min in an ice bath (treatment A). The other four samples were suspended in TM buffer containing 0.25 mg of lysostaphin per ml and incubated for 10 min, also in Centrifugation through TM buffer (group 1), followed by suspension in TM buffer (treatment A), as expected, had no effect on viable cell counts (Table 1) , the absorbance at 600 nm (Table 2) , or the absorbance at 260 nm (Table  3) . A greater than 99% reduction in viable counts was observed when these cells were suspended in lysostaphin solution (group 1, treatment B, Table 1 ). However, no strain showed a significant reduction in the A6W or an increase in the A260 of the supernatant. The decrease in viable count and low absorbance of the supernatants suggested that this treatment (group 1, treatment B) disrupted the cells to the degree that viability was lost, yet was not sufficient to completely lyse the cells in the time period. Cells which were centrifuged through lysostaphin ice without sucrose (group 2) appeared to lyse regardless of the suspending medium (treatment A or B, Table 1 ). Further examination, however, indicated that only treatment B had lysed the strains sufficiently to show either a substantial decrease in the A 6,0 or an increase in A260.
These results indicate that S. aureus can be lysed by suspension in buffer after centrifugation through lysostaphin ice. Lysostaphin need not be present in the suspension buffer, and the temperature at which lysis occurs can be as low as that of an ice bath. To demonstrate the desirability of low-temperature lysis, the following experiment was performed. Cell pellets of the three strains were lysed by treatment 3A or by incubation with lysostaphin solution at 35°C, each for 10 min, the time used for lysis above. After lysis, the extracts were incubated at ice bath temperatures, or 35°C, for either 10 or 30 min with deoxyribonucleic acid (DNA) added, and then the DNA was precipitated with perchloric acid (5) . Deoxyribonuclease activity was measured by the increase in absorbance at 260 nm of the supernatant after centrifugation, due to the formation of acid-soluble oligo-and mononucleotides. The data (Table 4) indicated, as expected,. that incubation at 2°C (3A) resulted in less DNA degradation than incubation at 35°C, and that a 10-min reaction time was superior to 30 min. Additional advantages of this lysis procedure (3A) include: (i) the amount of lysostaphin required is greatly reduced, thereby reducing costs; (ii) the use of surfaceactive agents and detergents were eliminated; (iii) the method is rapidly and easily performed, requiring no special equipment; and (iv) cell pellets can be stored frozen.
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